EurekAlert! -
25 Jun 2020 06:00
(University of Kent) A research team led by the University of Kent and Goethe-University Frankfurt am Main, has solved an almost 40-year old mystery in leukaemia therapy and the drug nelarabine, thanks to studying levels of enzyme SAMHD1.
Share this Article
Comment on this Article
Please to comment